{"id":97,"date":"2026-09-02T05:16:23","date_gmt":"2026-09-02T09:16:23","guid":{"rendered":"https:\/\/pauseproof.com\/articles\/perimenopause-no-periods-iud-pill\/"},"modified":"2026-09-19T02:00:02","modified_gmt":"2026-09-19T06:00:02","slug":"perimenopause-no-periods-iud-pill","status":"publish","type":"post","link":"https:\/\/pauseproof.com\/articles\/perimenopause-no-periods-iud-pill\/","title":{"rendered":"No Periods to Track: Recognising Perimenopause on the Pill, a Coil, or After Surgery"},"content":{"rendered":"\n

Hormonal contraception, an ablation or a hysterectomy removes the signal perimenopause is usually identified by. The research staging system says outright that it cannot stage you. What remains is your age, the pattern of your symptoms over months, and a blood test that UK guidance rules out entirely for some contraceptive users.<\/strong><\/p>\n\n\n\n

Almost everything written about spotting perimenopause starts with your cycle. Count the days, watch the gaps, note when it shortens. None of that works if your bleeding is set by a pill packet, reduced to nothing by a coil, or gone since surgery.<\/p>\n\n\n\n

Why does having no periods make perimenopause harder to identify?<\/h2>\n\n\n\n

Because the framework researchers use is built on bleeding. STRAW+10, published in 2012 and still the standard, marks entry to the early menopause transition by a persistent difference of seven days or more between consecutive cycle lengths. That is arithmetic performed on period start dates. Take the dates away and there is nothing to calculate.<\/p>\n\n\n\n

The STRAW+10 group was explicit about this. Women who have had a hysterectomy or an endometrial ablation cannot be staged by the bleeding criteria at all. For them, stage can only be approached through endocrine markers, and in most cases the result is a rough sorting into premenopausal or postmenopausal. The same problem applies to users of hormonal contraception and hormonal intrauterine devices, whose bleeding is produced by the method rather than the ovaries.<\/p>\n\n\n\n

One detail matters if surgery was recent: the staging group advised waiting at least three months afterwards before reading anything into endocrine results, because pelvic surgery can raise FSH temporarily. If your cycle has continued but changed only slightly, that is a different problem, covered in our piece on periods that are still regular<\/a>.<\/p>\n\n\n\n

\"Woman
STRAW+10 states plainly that its bleeding criteria cannot stage women after hysterectomy or ablation.<\/figcaption><\/figure>\n\n\n\n

Does a hormonal coil or the pill hide perimenopause, or only hide your periods?<\/h2>\n\n\n\n

It hides the bleeding. What it does to your symptoms, nobody can tell you from outside.<\/p>\n\n\n\n

A 52 mg levonorgestrel intrauterine system works mainly on the lining of the uterus, so bleeding becomes light or stops. How often it stops depends on who is counted. In contraceptive use, roughly one in five has no bleeding for 90 days or more by the end of the first year; a large multicentre trial reported 38.4% at 12 months among women who had used a system before; studies of women fitted for heavy bleeding have reported figures nearer 9% at one year. Different populations, not contradictory findings, and every number describes the endometrium, not the ovaries.<\/p>\n\n\n\n

The combined pill is a different mechanism with the same consequence. The bleed in the hormone free week is a withdrawal bleed triggered by stopping the hormones, and it arrives on schedule whether your own hormone production has changed or not.<\/p>\n\n\n\n

None of this is a reason to change or stop what you are using. That decision belongs with the person who prescribed it.<\/p>\n\n\n\n

What does each situation actually take away?<\/h2>\n\n\n\n
Situation<\/th>What happens to bleeding<\/th>Can bleeding based staging be used<\/th>What is left<\/th><\/tr><\/thead>
Combined pill, patch or ring<\/td>Regular withdrawal bleeds produced by the method<\/td>No. The pattern is set by the hormones you are taking<\/td>Symptom pattern over time; age<\/td><\/tr>
Progestogen only pill or implant<\/td>Often irregular, lighter, or absent<\/td>No. Bleeding is method driven<\/td>Symptom pattern over time; age<\/td><\/tr>
52 mg hormonal coil<\/td>Light or absent bleeding is expected<\/td>No. Absence of bleeding reflects the uterine lining<\/td>Symptom pattern over time; age<\/td><\/tr>
Endometrial ablation<\/td>Reduced or absent. Rates of no periods at 12 months run from about 15% to 72% by technique<\/td>STRAW+10 says no, and points to endocrine markers<\/td>Symptoms, age, hormone tests with their usual limits<\/td><\/tr>
Hysterectomy, ovaries kept<\/td>None at all<\/td>STRAW+10 says no, for the same reason<\/td>Symptoms, age, and ovarian function that may decline earlier<\/td><\/tr>
Hysterectomy with both ovaries removed<\/td>None at all<\/td>Not applicable. Menopause is immediate and surgical<\/td>A different clinical situation, managed as one<\/td><\/tr><\/tbody><\/table>
What each situation removes from the usual route, and what remains.<\/figcaption><\/figure>\n\n\n\n

Can a blood test settle it when there are no periods to go by?<\/h2>\n\n\n\n

Not cleanly, and the guideline itself is where the difficulty shows up.<\/p>\n\n\n\n

NICE guideline NG23, updated on 7 November 2024, says that in otherwise healthy people aged 45 and over, perimenopause is identified without laboratory tests, from vasomotor symptoms together with a change in the menstrual cycle. Read that back with a hormonal coil in place. Half the identification route is a cycle change you cannot observe, and NICE sets out no separate route for people whose bleeding has been removed by a method or by surgery. The guidance is not wrong. It was not written with this reader in the frame.<\/p>\n\n\n\n

Between 40 and 45 NICE takes a different line and says a serum FSH test can be considered in people with menopausal symptoms including a cycle change, which matters for anyone who has been told they are too young for perimenopause<\/a>. Then the two lines collide, because NICE also advises against using an FSH test to identify menopause in people using combined oestrogen and progestogen contraception or high dose progestogen. For a 42 year old on the combined pill, one recommendation invites the test and the other rules it out, and the second is the one that applies.<\/p>\n\n\n\n

Faculty of Sexual and Reproductive Healthcare guidance for women over 40 arrives at the same place from another angle: attention belongs on symptoms rather than FSH levels unless premature menopause is a concern, and isolated readings of FSH, oestradiol and luteinising hormone during perimenopause can be misleading and should not drive advice about stopping contraception, which can be continued until 55.<\/p>\n\n\n\n

The reason is the one that also catches women who still have periods: a normal hormone result rules out less than people think<\/a>.<\/p>\n\n\n\n

\"Woman
FSRH guidance warns that isolated hormone readings in perimenopause can be misleading.<\/figcaption><\/figure>\n\n\n\n

Does a hysterectomy change when perimenopause starts?<\/h2>\n\n\n\n

It may bring ovarian decline forward, even when the ovaries are left in place. That is one of the firmer findings here, and one where the reported effect size does not agree with itself.<\/p>\n\n\n\n

The study most often cited is a 2011 prospective cohort in Obstetrics and Gynecology<\/em> by Patricia Moorman and colleagues: 406 women aged 30 to 47 who had a hysterectomy without removal of both ovaries, alongside 465 with intact uteri, sampled annually for up to five years. Ovarian failure was more common after hysterectomy even among women who kept both ovaries, hazard ratio 1.74 (95% confidence interval 1.14 to 2.65), rising to 2.93 where one ovary had also been removed.<\/p>\n\n\n\n

\n

How much earlier is where the sources part company. The university’s own announcement put it at approximately two years, with 14.8% of the hysterectomy group reaching menopause during follow up against 8% of controls. Summaries drawn from the published abstract circulate a figure closer to three years, with a confidence interval of 1.5 to 6.0 years. The direction is consistent. The size is not, and the paper sits behind a paywall.<\/p>\n<\/blockquote>\n\n\n\n

Why it happens is unresolved. Surgery may disrupt blood supply to the ovaries, or the condition that led to the hysterectomy may itself have been a marker of something already underway.<\/p>\n\n\n\n

Endometrial ablation is a different case. It treats the lining of the uterus and does not touch the ovaries, so there is no reason to expect it to move the timing of anything. What it removes is the ability to see the timing.<\/p>\n\n\n\n

What can you use instead of a period diary?<\/h2>\n\n\n\n

The staging group proposed an answer in the same document that ruled out staging this group: formal recognition that the onset of moderately to severely bothersome vasomotor symptoms signals the transition in women without regular bleeding, including those with a hormonal intrauterine device or after hysterectomy or ablation. That was a recommendation for the field in 2012, not a diagnostic test, and it has not become one.<\/p>\n\n\n\n

What it does establish is that symptom onset carries information, and onset can be recorded. The Flo Health and Mayo Clinic survey of 17,494 participants across 158 countries, published in Menopause<\/em> in 2026, is a useful map of what to watch. Among the 12,681 respondents aged 35 and over, 83.2% reported fatigue, 83.2% physical and mental exhaustion, 80% irritability and 76% digestive changes. A separate question, put to 17,290 respondents of all ages, found the symptoms people associate with perimenopause were hot flashes at 71.1%, sleep problems at 67.5% and weight gain at 65.2%. Two groups, two questions, no statistical test of the difference. They still point one way: what gets watched for and what gets lived through are different lists, with fatigue and exhaustion<\/a> the clearest example.<\/p>\n\n\n\n

What is worth taking to an appointment is closer to a log than a diary:<\/p>\n\n\n\n